Acute exacerbation of psychiatric symptoms during influenza treatment with oseltamivir in chronic schizophrenia
Author(s) -
ChenChia Lan,
ChiaChien Liu,
Ying-Sheue Chen
Publication year - 2015
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.535
H-Index - 42
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1016/j.jcma.2014.05.017
Subject(s) - oseltamivir , medicine , exacerbation , psychiatry , schizophrenia (object oriented programming) , mania , depression (economics) , bipolar disorder , covid-19 , cognition , disease , infectious disease (medical specialty) , economics , macroeconomics
Influenza treatment and prophylaxis with oseltamivir are critically important in reducing the morbidity and mortality of patients in chronic psychiatric facilities. Abnormal behavior, delusions, perceptual disturbances, mania, and depression have all been reported as oseltamivir-related psychiatric side effects. We hereby report two chronic schizophrenia patients in Taiwan manifesting psychiatric instability who were being treated with oseltamivir for suspected influenza infection, and further discuss other potential contributing factors. The possibility that oseltamivir can cause psychotic or affective symptoms suggests that additional caution is necessary for its use in patients with an established psychiatric diagnosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom